BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26129739)

  • 1. Occult Temporal Bone Facial Nerve Involvement by Parotid Malignancies with Perineural Spread.
    Carlson ML; Patel NS; Modest MC; Moore EJ; Janus JR; Olsen KD
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):385-91. PubMed ID: 26129739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased local recurrence in advanced parotid malignancy treated with mastoidectomy without lateral temporal bone resection.
    Kadakia S; Chan D; Ducic Y; Cristobal R; Mourad M
    Oral Maxillofac Surg; 2017 Mar; 21(1):7-11. PubMed ID: 27696236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perineural Invasion in Parotid Gland Malignancies.
    Huyett P; Duvvuri U; Ferris RL; Johnson JT; Schaitkin BM; Kim S
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1035-1041. PubMed ID: 29337642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral temporal bone and parotid malignancy with facial nerve involvement.
    Mantravadi AV; Marzo SJ; Leonetti JP; Fargo KN; Carter MS
    Otolaryngol Head Neck Surg; 2011 Mar; 144(3):395-401. PubMed ID: 21493202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional spread of nonneurogenic tumors to the skull base via the facial nerve.
    Selesnick SH; Burt BM
    Otol Neurotol; 2003 Mar; 24(2):326-33. PubMed ID: 12621352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The results of temporal bone surgery for advanced or recurrent tumors of the parotid gland.
    Gidley PW; Thompson CR; Roberts DB; Weber RS
    Laryngoscope; 2011 Aug; 121(8):1702-7. PubMed ID: 21792957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.
    Terakedis BE; Hunt JP; Buchmann LO; Avizonis VN; Anker CJ; Hitchcock YJ
    Am J Clin Oncol; 2017 Jun; 40(3):323-328. PubMed ID: 25503431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perineural Invasion of the Intratemporal Facial Nerve: How Far Proximally Do We Chase the Positive Margin?
    Page JC; Nader ME; Knackstedt M; Roberts D; Gidley PW
    Otol Neurotol; 2021 Dec; 42(10):1572-1579. PubMed ID: 34411066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function.
    Guntinas-Lichius O; Klussmann JP; Schroeder U; Quante G; Jungehuelsing M; Stennert E
    Laryngoscope; 2004 May; 114(5):949-56. PubMed ID: 15126763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and non-primary parotid malignancies: comparison of treatment modalities and outcomes.
    Morinière S; Périé S; Lacau St Guily J
    Eur Arch Otorhinolaryngol; 2007 Oct; 264(10):1231-7. PubMed ID: 17534637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Parotid Malignancies—10 Years of Experience.
    Kopeć T; Mikaszewski B; Jackowska J; Waśniewska-Okupniak E; Szyfter W; Wierzbicka M
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1397-402. PubMed ID: 25850920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoid cystic carcinoma of the parotid gland presenting as temporal bone neoplasm: a case report.
    Selcuk A; Dere H; Bahar S; Sarikaya Y; Ozcan M
    B-ENT; 2007; 3(3):153-6. PubMed ID: 17970441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoid cystic carcinoma of the parotid with facial nerve invasion.
    Ayadi K; Ayadi L; Daoud E; Mnif Z; Ben Mahfoudh K; Boudawara T; Mnif J
    Tunis Med; 2010 Jan; 88(1):46-8. PubMed ID: 20415214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preauricular infratemporal fossa approach for advanced malignant parotid tumors.
    Leonetti JP; Benscoter BJ; Marzo SJ; Borrowdale RW; Pontikis GC
    Laryngoscope; 2012 Sep; 122(9):1949-53. PubMed ID: 22740432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parotidectomy in the treatment of aggressive cutaneous malignancies.
    Lai SY; Weinstein GS; Chalian AA; Rosenthal DI; Weber RS
    Arch Otolaryngol Head Neck Surg; 2002 May; 128(5):521-6. PubMed ID: 12003582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative parotidectomy for the treatment of parotid cancers.
    Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
    Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtotal petrosectomy in the management of advanced parotid neoplasms.
    Leonetti JP; Smith PG; Anand VK; Kletzker GR; Hartman JM
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):270-6. PubMed ID: 8464641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and management of facial nerve in patients with parotid gland cancer and pretreatment facial weakness.
    Park W; Park J; Park SI; Kim H; Bae H; Cho J; Won H; Park M; Jeong HS
    Oral Oncol; 2019 Feb; 89():144-149. PubMed ID: 30732953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the margin in parotid surgery for pleomorphic adenoma.
    Witt RL
    Laryngoscope; 2002 Dec; 112(12):2141-54. PubMed ID: 12461331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.